STOCK TITAN

[144] CeriBell, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

CeriBell, Inc. (CBLL) Form 144: This notice reports a proposed sale of 7,032 shares of common stock through Fidelity Brokerage Services on 08/19/2025 with an aggregate market value of $82,690.42 and 36,663,968 shares outstanding. The shares were acquired via restricted stock vesting from the issuer: 414 shares vested on 06/01/2025 and 6,618 shares vested on 06/10/2025, with payment characterized as compensation. The filer states there were no securities sold in the past three months for the account reported and affirms no undisclosed material adverse information is known.

CeriBell, Inc. (CBLL) Modulo 144: Avviso di una proposta di vendita di 7.032 azioni ordinarie tramite Fidelity Brokerage Services in data 19/08/2025, per un valore di mercato complessivo di $82.690,42, con 36.663.968 azioni in circolazione. Le azioni sono state ottenute mediante vesting di azioni soggette a restrizioni dall'emittente: 414 azioni sono diventate di proprietà il 01/06/2025 e 6.618 azioni il 10/06/2025, con il pagamento classificato come compenso. Il dichiarante segnala che, nei tre mesi precedenti, non sono stati venduti titoli per il conto indicato e conferma di non essere a conoscenza di informazioni negative materiali non divulgate.

CeriBell, Inc. (CBLL) Formulario 144: Aviso de una propuesta de venta de 7.032 acciones ordinarias a través de Fidelity Brokerage Services el 19/08/2025, con un valor de mercado agregado de $82.690,42 y 36.663.968 acciones en circulación. Las acciones se adquirieron por vesting de acciones restringidas del emisor: 414 acciones adquiridas el 01/06/2025 y 6.618 el 10/06/2025, con el pago catalogado como compensación. El declarante indica que no se vendieron valores en los últimos tres meses para la cuenta informada y afirma no tener conocimiento de información material adversa no divulgada.

CeriBell, Inc. (CBLL) Form 144: 이 통지는 2025-08-19에 Fidelity Brokerage Services를 통해 7,032주의 보통주를 매도할 예정임을 보고하며, 총 시가 가치는 $82,690.42이고 발행 주식 수는 36,663,968주입니다. 해당 주식은 발행사로부터의 제한부 주식 베스팅을 통해 취득되었으며: 414주가 2025-06-01에 베스트되었고 6,618주가 2025-06-10에 베스트되었으며, 지급은 보상으로 분류됩니다. 제출자는 보고된 계좌에 대해 최근 3개월 내에 매도된 증권이 없음을 밝히고, 공개되지 않은 중대한 불리한 정보가 없음을 확인합니다.

CeriBell, Inc. (CBLL) Formulaire 144 : Cet avis signale une proposition de vente de 7 032 actions ordinaires via Fidelity Brokerage Services le 19/08/2025, pour une valeur de marché totale de $82 690,42 et 36 663 968 actions en circulation. Les actions ont été acquises par vesting d'actions restreintes de l'émetteur : 414 actions sont devenues acquises le 01/06/2025 et 6 618 actions le 10/06/2025, le paiement étant qualifié de rémunération. Le déclarant indique qu'aucun titre n'a été vendu au cours des trois derniers mois pour le compte déclaré et affirme ne pas être au courant d'informations défavorables matérielles non divulguées.

CeriBell, Inc. (CBLL) Formular 144: Diese Mitteilung berichtet über einen geplanten Verkauf von 7.032 Stammaktien über Fidelity Brokerage Services am 19.08.2025 mit einem aggregierten Marktwert von $82.690,42 bei insgesamt 36.663.968 ausstehenden Aktien. Die Aktien wurden durch Vesting eingeschränkter Aktien vom Emittenten erworben: 414 Aktien sind am 01.06.2025 freigeworden und 6.618 Aktien am 10.06.2025, die Zahlung wird als Vergütung eingestuft. Der Einreicher gibt an, dass in den vergangenen drei Monaten keine Wertpapiere für das gemeldete Konto verkauft wurden, und bestätigt, dass ihm keine nicht offengelegten wesentlichen negativen Informationen bekannt sind.

Positive
  • Transparent disclosure of the proposed sale including broker, number of shares, aggregate market value, and sale date
  • Clear acquisition details showing shares resulted from restricted stock vesting and were paid as compensation
  • No prior sales reported in the past three months for the account, simplifying Rule 144 aggregation
Negative
  • None.

Insights

TL;DR: Insider proposes to sell newly vested shares totaling 7,032 common shares for ~$82.7k through Fidelity on 08/19/2025.

This Form 144 discloses a routine planned sale by a person whose restricted stock vested in June 2025. The sale is being executed through a broker and the filer reports no sales in the prior three months. The filing provides clear acquisition dates and identifies the shares as compensation, which is typical for insider vesting and subsequent Rule 144 disposal. For investors, this is a transparent compliance filing rather than evidence of corporate distress or material corporate change; it documents a personal liquidity event tied to compensation.

TL;DR: Disclosure follows Rule 144 mechanics: vested compensation shares to be sold; signer attests no undisclosed material information.

The form includes necessary seller representations and broker details, and notes that the filer affirms absence of material nonpublic information. The filing identifies the nature of acquisition as restricted stock vesting and the payment as compensation, which supports standard insider reporting and governance transparency. No prior three-month disposals are reported, simplifying aggregation concerns under Rule 144 for this proposed sale.

CeriBell, Inc. (CBLL) Modulo 144: Avviso di una proposta di vendita di 7.032 azioni ordinarie tramite Fidelity Brokerage Services in data 19/08/2025, per un valore di mercato complessivo di $82.690,42, con 36.663.968 azioni in circolazione. Le azioni sono state ottenute mediante vesting di azioni soggette a restrizioni dall'emittente: 414 azioni sono diventate di proprietà il 01/06/2025 e 6.618 azioni il 10/06/2025, con il pagamento classificato come compenso. Il dichiarante segnala che, nei tre mesi precedenti, non sono stati venduti titoli per il conto indicato e conferma di non essere a conoscenza di informazioni negative materiali non divulgate.

CeriBell, Inc. (CBLL) Formulario 144: Aviso de una propuesta de venta de 7.032 acciones ordinarias a través de Fidelity Brokerage Services el 19/08/2025, con un valor de mercado agregado de $82.690,42 y 36.663.968 acciones en circulación. Las acciones se adquirieron por vesting de acciones restringidas del emisor: 414 acciones adquiridas el 01/06/2025 y 6.618 el 10/06/2025, con el pago catalogado como compensación. El declarante indica que no se vendieron valores en los últimos tres meses para la cuenta informada y afirma no tener conocimiento de información material adversa no divulgada.

CeriBell, Inc. (CBLL) Form 144: 이 통지는 2025-08-19에 Fidelity Brokerage Services를 통해 7,032주의 보통주를 매도할 예정임을 보고하며, 총 시가 가치는 $82,690.42이고 발행 주식 수는 36,663,968주입니다. 해당 주식은 발행사로부터의 제한부 주식 베스팅을 통해 취득되었으며: 414주가 2025-06-01에 베스트되었고 6,618주가 2025-06-10에 베스트되었으며, 지급은 보상으로 분류됩니다. 제출자는 보고된 계좌에 대해 최근 3개월 내에 매도된 증권이 없음을 밝히고, 공개되지 않은 중대한 불리한 정보가 없음을 확인합니다.

CeriBell, Inc. (CBLL) Formulaire 144 : Cet avis signale une proposition de vente de 7 032 actions ordinaires via Fidelity Brokerage Services le 19/08/2025, pour une valeur de marché totale de $82 690,42 et 36 663 968 actions en circulation. Les actions ont été acquises par vesting d'actions restreintes de l'émetteur : 414 actions sont devenues acquises le 01/06/2025 et 6 618 actions le 10/06/2025, le paiement étant qualifié de rémunération. Le déclarant indique qu'aucun titre n'a été vendu au cours des trois derniers mois pour le compte déclaré et affirme ne pas être au courant d'informations défavorables matérielles non divulguées.

CeriBell, Inc. (CBLL) Formular 144: Diese Mitteilung berichtet über einen geplanten Verkauf von 7.032 Stammaktien über Fidelity Brokerage Services am 19.08.2025 mit einem aggregierten Marktwert von $82.690,42 bei insgesamt 36.663.968 ausstehenden Aktien. Die Aktien wurden durch Vesting eingeschränkter Aktien vom Emittenten erworben: 414 Aktien sind am 01.06.2025 freigeworden und 6.618 Aktien am 10.06.2025, die Zahlung wird als Vergütung eingestuft. Der Einreicher gibt an, dass in den vergangenen drei Monaten keine Wertpapiere für das gemeldete Konto verkauft wurden, und bestätigt, dass ihm keine nicht offengelegten wesentlichen negativen Informationen bekannt sind.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does CeriBell (CBLL) Form 144 report?

The form reports a proposed sale of 7,032 common shares through Fidelity on 08/19/2025 with aggregate market value $82,690.42.

How were the shares acquired that are being sold under this CBLL filing?

The shares were acquired via restricted stock vesting: 414 shares on 06/01/2025 and 6,618 shares on 06/10/2025, with payment characterized as compensation.

Who is the broker handling the proposed sale in the Form 144?

The broker listed is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI 02917.

Did the filer report any securities sold in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

Does the filer assert knowledge of any undisclosed material information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

446.57M
28.87M
10.39%
84.34%
3.46%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE